These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 680382)

  • 1. Human rabies immunoprophylaxis using HDC (MRC-5) vaccine.
    Cox JH; Klietmann W; Schneider LG
    Dev Biol Stand; 1978; 40():105-8. PubMed ID: 680382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rabies post-exposure treatment and side-effects in man using HDC (MRC 5) vaccine.
    Klietmann W; Domres B; Cox JH
    Dev Biol Stand; 1978; 40():109-13. PubMed ID: 567152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preventive rabies vaccination using vaccine prepared from human diploid cells].
    Costy-Berger F
    Dev Biol Stand; 1978; 40():101-4. PubMed ID: 680381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-exposure use of human diploid cell culture rabies vaccine.
    Kuwert EK; Marcus I; Werner J; Scheiermann N; Höher PG; Thraenhart O; Hierholzer E; Wiktor TJ; Koprowski H
    Dev Biol Stand; 1976 Dec 13-15; 37():273-86. PubMed ID: 1031689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals].
    Baysal B; Tosun S; Ozdemir M; Doğan M
    Mikrobiyol Bul; 2009 Jan; 43(1):127-31. PubMed ID: 19334389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of purified vero cell rabies vaccine used in the treatment of fox-bite victims in India.
    Matha IS; Salunke SR
    Clin Infect Dis; 2005 Feb; 40(4):611-3. PubMed ID: 15712086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serovaccination by human immune globulin and HDCS-vaccine against rabies.
    Kuwert EK; Werner J; Marcus I; Cabasso VJ
    Dev Biol Stand; 1978; 40():129-36. PubMed ID: 680386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the inactivated tissue culture rabies vaccine from the Vnukovo-32 strain. Results of its industrial production and field use for post-exposure immunization of man.
    Selimov M; Aksenova T; Klyueva E; Gribencha L; Lebedeva I
    Dev Biol Stand; 1978; 40():57-62. PubMed ID: 680402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human rabies globulin and human diploid vaccine dose determinations.
    Hafkin B; Alls ME; Baer GM
    Dev Biol Stand; 1978; 40():121-7. PubMed ID: 680385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroconversion following incomplete human rabies postexposure prophylaxis.
    Robertson K; Recuenco S; Niezgoda M; Garcia EJ; Rupprecht CE
    Vaccine; 2010 Sep; 28(39):6523-6. PubMed ID: 20637309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of patients bitten by rabid or suspected rabid wolves with inactivated tissue culture rabies vaccine and rabies gammaglobulin.
    Selimov MA; Klyueva EV; Aksenova TA; Lebedeva IR; Gribencha LF
    Dev Biol Stand; 1978; 40():141-6. PubMed ID: 79511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.
    Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C
    Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabies antibody seroprotection rates among travelers in Nepal: "rabies seroprotection in travelers".
    Ranney M; Partridge R; Jay GD; Rozzoli DE; Pandey P
    J Travel Med; 2006; 13(6):329-33. PubMed ID: 17107424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some experiences with human diploid cell strain-(HDCS) rabies vaccine in pre- and post-exposure vaccinated humans.
    Kuwert EK; Marcus I; Werner J; Iwand A; Thraenhart O
    Dev Biol Stand; 1978; 40():79-88. PubMed ID: 680404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe.
    Kamoltham T; Thinyounyong W; Phongchamnaphai P; Phraisuwan P; Khawplod P; Banzhoff A; Malerczyk C
    J Pediatr; 2007 Aug; 151(2):173-7. PubMed ID: 17643772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative immunogenicity of 2 antirabies vaccines in a 2-1-1 post-exposure vaccination schedule].
    Landry P; Lazzaro M; Darioli R
    Praxis (Bern 1994); 1998 Sep; 87(37):1177-9. PubMed ID: 9785997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BHK-21 cell culture rabies vaccine: immunogenicity of a candidate vaccine for humans.
    Lalosević D; Lalosević V; Lazarević-Ivanc Lj; Knezević I
    Dev Biol (Basel); 2008; 131():421-9. PubMed ID: 18634504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of preventive rabies vaccination with a concentrated vaccine of the PM/WI38-1503-3M rabies strain cultured on human diploid cells. Preparation of mixed antirabies-antitetanus hyperimmune immunoglobulin by plasmapheresis of blood taken from vaccinated veterinary students].
    Ajjan N; Soulebot JP; Stellmann C; Biron G; Charbonnier C; Triau R; Mérieux C
    Dev Biol Stand; 1978; 40():89-100. PubMed ID: 680405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
    Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C
    Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of a competitive ELISA for estimation of rabies neutralizing antibodies after post-exposure rabies vaccination in humans.
    Muhamuda K; Madhusudana SN; Ravi V
    Int J Infect Dis; 2007 Sep; 11(5):441-5. PubMed ID: 17321182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.